Does It Matter Who Provides Psychological Interventions for Medically Unexplained Symptoms? A Meta-AnalysisGerger H.a, b · Hlavica M.a · Gaab J.b · Munder T.a · Barth J.a, c
aInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, bDivision of Clinical Psychology and Psychotherapy, Department of Psychology, University of Basel, Basel, and cInstitute for Complementary and Integrative Medicine, University Hospital Zürich and University of Zürich, Zürich, Switzerland
Do you have an account?
- Rent for 48h to view
- Buy Cloud Access for unlimited viewing via different devices
- Synchronizing in the ReadCube Cloud
- Printing and saving restrictions apply
Rental: USD 8.50
Cloud: USD 20.00
Article / Publication Details
Background: Patients with medically unexplained symptoms (MUS) are difficult to treat and cause high health-care costs. Psychological interventions might be a beneficial option for treating patients with MUS, but evidence is inconsistent. This meta-analysis compares the effectiveness of psychological interventions for MUS - delivered either by psychotherapists (PTs) or by general practitioners (GPs) - with that of usual care. Method: We conducted a systematic review and meta-analysis on randomised controlled trials of psychological interventions for MUS. Physical symptoms were the primary outcome, and physical functioning and psychological symptoms were the secondary outcomes. We pooled between-group effect sizes (ESs) after the treatment and at the follow-up in random-effects meta-regressions and stratified meta-analyses. We repeated these analyses with the intervention provider, intervention dose, MUS severity and methodological quality as predictors of relative intervention effects. Results: A total of 3,225 patients in 20 studies were analysed. After the treatment, small and significant ESs were found for all 3 outcome domains (ES range: 0.13-0.19, all p < 0.05). Psychological interventions were more beneficial for physical symptoms when delivered by PTs than by GPs (p = 0.02). There was no difference between PTs and GPs in terms of physical functioning and psychological symptoms. Conclusion: Psychological interventions are effective for patients with MUS, but the effects are small and most likely of short duration. Interventions that are delivered by PTs appear to have larger effects on unexplained physical symptoms than those delivered by GPs. Whether this superiority is due to a larger number of sessions of PT interventions remains unclear from our findings.
© 2015 S. Karger AG, Basel
- Fink P, Hansen MS, Oxhøj M-L: The prevalence of somatoform disorders among internal medical inpatients. J Psychosom Res 2004;56:413-418.
- Gureje O, Simon GE: The natural history of somatization in primary care. Psychol Med 1999;29:669-676.
- Nimnuan C, Hotopf M, Wessely S: Medically unexplained symptoms: an epidemiological study in seven specialities. J Psychosom Res 2001;51:361-367.
- Toft T, Fink P, Oernboel E, Christensen K, Frostholm L, Olesen F: Mental disorders in primary care: prevalence and co-morbidity among disorders. Results from the functional illness in primary care (FIP) study. Psychol Med 2005;35:1175-1184.
- Brown RJ: Introduction to the special issue on medically unexplained symptoms: background and future directions. Clin Psychol Rev 2007;27:769-780.
- olde Hartman TC, Borghuis MS, Lucassen PLBJ, van de Laar FA, Speckens AE, van Weel C: Medically unexplained symptoms, somatisation disorder and hypochondriasis: course and prognosis. A systematic review. J Psychosom Res 2009;66:363-377.
- Fava GA, Guidi J, Porcelli P, Rafanelli C, Bellomo A, Grandi S, Grassi L, Mangelli L, Pasquini P, Picardi A, Quartesan R, Rigatelli M, Sonino N: A cluster analysis-derived classification of psychological distress and illness behavior in the medically ill. Psychol Med 2012;42:401-407.
- Klaus K, Rief W, Brähler E, Martin A, Glaesmer H, Mewes R: The distinction between ‘medically unexplained' and ‘medically explained' in the context of somatoform disorders. Int J Behav Med 2013;20:161-171.
- Dimsdale J, Sharma N, Sharpe M: What do physicians think of somatoform disorders? Psychosomatics 2011;52:154-159.
- Wessely S, White PD: There is only one functional somatic syndrome. Br J Psychiatry 2004;185:95-96.
- American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, ed 5. Arlington, American Psychiatric Publishing, 2013.
- Fava GA, Freyberger HJ, Bech P, Christodoulou G, Sensky T, Theorell T, Wise TN: Diagnostic criteria for use in psychosomatic research. Psychother Psychosom 1995;63:1-8.
- Sirri L, Fava GA: Diagnostic criteria for psychosomatic research and somatic symptom disorders. Int Rev Psychiatry 2013;25:19-30.
- van Dessel N, den Boeft M, van der Wouden JC, Kleinstäuber M, Leone SS, Terluin B, Numans ME, van der Horst HE, van Marwijk H: Non-pharmacological interventions for somatoform disorders and medically unexplained physical symptoms (MUPS) in adults. Cochrane Database Syst Rev 2014;11:CD011142.
- Barsky AJ, Orav EJ, Bates DW: Somatization increases medical utilization and costs independent of psychiatric and medical comorbidity. Arch Gen Psychiatry 2005;62:903-910.
- Konnopka A, Schaefert R, Heinrich S, Kaufmann C, Luppa M, Herzog W, König HH: Economics of medically unexplained symptoms: a systematic review of the literature. Psychother Psychosom 2012;81:265-275.
- Arnold IA, de Waal MWM, Eekhof JAH, van Hemert AM: Somatoform disorder in primary care: course and the need for cognitive- behavioral treatment. Psychosomatics 2006;47:498-503.
- Kleinstäuber M, Witthöft M, Hiller W: Efficacy of short-term psychotherapy for multiple medically unexplained physical symptoms: a meta-analysis. Clin Psychol Rev 2011;31:146-160.
- Kroenke K: Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 2007;69:881-888.
- Looper KJ, Kirmayer LJ: Behavioral medicine approaches to somatoform disorders. J Consult Clin Psychol 2002;70:810-827.
- Nezu AM, Nezu CM, Lombardo ER: Cognitive-behavior therapy for medically unexplained symptoms: a critical review of the treatment literature. Behav Ther 2001;32:537-583.
- Sumathipala A: What is the evidence for the efficacy of treatments for somatoform disorders? A critical review of previous intervention studies. Psychosom Med 2007;69:889-900.
- Koelen JA, Houtveen JH, Abbass A, Luyten P, Eurelings-Bontekoe EH, Van Broeckhuysen-Kloth SA, Bühring ME, Geenen R: Effectiveness of psychotherapy for severe somatoform disorder: meta-analysis. Br J Psychiatry 2014;204:12-19.
- Escobar JI, Burnam MA, Karno M, Forsythe A, Golding JM: Somatization in the community. Arch Gen Psychiatry 1987;44:713-718.
- Jüni P, Altman DG, Egger M: Assessing the quality of controlled clinical trials. BMJ 2001;323:42-46.
- Wood L, Egger M, Gluud LL, Schulz KF, Jüni P, Altman DG, Gluud C, Martin RM, Wood AJG, Sterne JAC: Empirical evidence of bias in treatment effect estimates in controlled trials with different interventions and outcomes: meta-epidemiological study. BMJ 2008;336:601-605.
- Nüesch E, Trelle S, Reichenbach S, Rutjes AWS, Bürgi E, Scherer M, Altman DG, Jüni P: The effects of excluding patients from the analysis in randomised controlled trials: meta-epidemiological study. BMJ 2009;339:b3244.
Hedges LV, Olkin I: Statistical Methods for Meta-Analysis. New York, Academic Press, 1985.
Cohen J: Statistical Power Analysis for the Behavioral Sciences, ed 2. Hillsdale, Erlbaum, 1988.
Lipsey MW, Wilson DB: Practical Meta-Analysis. Thousand Oaks, Sage, 2001.
- Cuijpers P, van Straten A, Bohlmeijer E, Hollon SD, Andersson G: The effects of psychotherapy for adult depression are overestimated: a meta-analysis of study quality and effect size. Psychol Med 2010;40:211-223.
- Knapp G, Hartung J: Improved tests for a random effects meta-regression with a single covariate. Stat Med 2003;22:2693-2710.
- Higgins JPT, Thompson SG: Controlling the risk of spurious findings from meta-regression. Stat Med 2004;23:1663-1682.
- Shadish WR, Sweeney RB: Mediators and moderators in meta-analysis: there's a reason we don't let dodo birds tell us which psychotherapies should have prizes. J Consult Clin Psychol 1991;59:883-893.
- Higgins JPT: Commentary: Heterogeneity in meta-analysis should be expected and appropriately quantified. Int J Epidemiol 2008;37:1158-1160.
- Rücker G, Schwarzer G, Carpenter JR, Schumacher M: Undue reliance on I2 in assessing heterogeneity may mislead. BMC Med Res Methodol 2008;8:79.
Harris RJ, Bradburn MJ, Deeks JJ, Harbord RM, Altman DG, Steichen TJ, Sterne JAC: METAN: Stata module for fixed and random effects meta-analysis. Boston College Department of Economics, 2006.
- Egger M, Smith GD, Schneider M, Minder C: Bias in meta-analysis detected by a simple, graphical test. BMJ 1997;315:629-634.
- Aiarzaguena JM, Grandes G, Gaminde I, Salazar A, Sánchez A, Ariño J: A randomized controlled clinical trial of a psychosocial and communication intervention carried out by GPs for patients with medically unexplained symptoms. Psychol Med 2007;37:283-294.
- Allen LA, Woolfolk RL, Escobar JI, Gara MA, Hamer RM: Cognitive-behavioral therapy for somatization disorder: a randomized controlled trial. Arch Intern Med 2006;166:1512-1518.
- Arnold IA, de Waal MW, Eekhof JA, Assendelft WJ, Spinhoven P, van Hemert AM: Medically unexplained physical symptoms in primary care: a controlled study on the effectiveness of cognitive-behavioral treatment by the family physician. Psychosomatics 2009;50:515-524.
- Escobar JI, Gara MA, Diaz-Martinez AM, Interian A, Warman M, Allen LA, Woolfolk RL, Jahn E, Rodgers D: Effectiveness of a time-limited cognitive behavior therapy type intervention among primary care patients with medically unexplained symptoms. Ann Fam Med 2007;5:328-335.
- Kocken PL, Joosten-van Zwanenburg E, de Hoop T: Effects of health education for migrant females with psychosomatic complaints treated by general practitioners. Patient Educ Couns 2008;70:25-30.
- Kolk AMM, Schagen S, Hanewald GJFP: Multiple medically unexplained physical symptoms and health care utilization: outcome of psychological intervention and patient-related predictors of change. J Psychosom Res 2004;57:379-389.
- Larisch A, Schweickhardt A, Wirsching M, Fritzsche K: Psychosocial interventions for somatizing patients by the general practitioner: a randomized controlled trial. J Psychosom Res 2004;57:507-514.
- Morriss R, Dowrick C, Salmon P, Peters S, Dunn G, Rogers A, Lewis B, Charles-Jones H, Hogg J, Clifford R, Rigby C, Gask L: Cluster randomised controlled trial of training practices in reattribution for medically unexplained symptoms. Br J Psychiatry 2007;191:536-542.
Pols RG, Battersby MW: Coordinated care in the management of patients with unexplained physical symptoms: depression is a key issue. Med J Aust 2008;188(suppl 12):S133-S137.
Posse M: Jungian psychotherapy for somatization. Eur J Psychiatry 2004;18:23-29.
- Rosendal M, Olesen F, Fink P, Toft T, Sokolowski I, Bro F: A randomized controlled trial of brief training in the assessment and treatment of somatization in primary care: effects on patient outcome. Gen Hosp Psychiatry 2007;29:364-373.
- Schilte AF, Portegijs PJ, Blankenstein AH, van der Horst HE, Latour MB, van Eijk JT, Knottnerus JA: Randomised controlled trial of disclosure of emotionally important events in somatisation in primary care. BMJ 2001;323:86.
- Schweickhardt A, Larisch A, Wirsching M, Fritzsche K: Short-term psychotherapeutic interventions for somatizing patients in the general hospital: a randomized controlled study. Psychother Psychosom 2007;76:339-346.
- Smith RC, Gardiner JC, Luo Z, Schooley S, Lamerato L, Rost K: Primary care physicians treat somatization. J Gen Intern Med 2009;24:829-832.
- Smith RC, Lyles JS, Gardiner JC, Sirbu C, Hodges A, Collins C, Dwamena FC, Lein C, William Given C, Given B, Goddeeris J: Primary care clinicians treat patients with medically unexplained symptoms: a randomized controlled trial. J Gen Intern Med 2006;21:671-677.
- Speckens AE, van Hemert AM, Spinhoven P, Hawton KE, Bolk JH, Rooijmans HG: Cognitive behavioural therapy for medically unexplained physical symptoms: a randomised controlled trial. BMJ 1995;311:1328-1332.
- Sumathipala A, Hewege S, Hanwella R, Mann AH: Randomized controlled trial of cognitive behaviour therapy for repeated consultations for medically unexplained complaints: a feasibility study in Sri Lanka. Psychol Med 2000;30:747-757.
- Sumathipala A, Siribaddana S, Abeysingha MR, de Silva P, Dewey M, Prince M, Mann AH: Cognitive-behavioural therapy versus structured care for medically unexplained symptoms: randomised controlled trial. Br J Psychiatry 2008:51-59.
- Toft T, Rosendal M, Ørnbøl E, Olesen F, Frostholm L, Fink P: Training general practitioners in the treatment of functional somatic symptoms: effects on patient health in a cluster-randomised controlled trial. Psychother Psychosom 2010;79:227-237.
- van der Feltz-Cornelis CM, van Oppen P, Adèr HJ, van Dyck R: Randomised controlled trial of a collaborative care model with psychiatric consultation for persistent medically unexplained symptoms in general practice. Psychother Psychosom 2006;75:282-289.
- Khan AA, Khan A, Harezlak J, Tu W, Kroenke K: Somatic symptoms in primary care: etiology and outcome. Psychosomatics 2003;44:471-478.
- Guidi J, Rafanelli C, Roncuzzi R, Sirri L, Fava GA: Assessing psychological factors affecting medical conditions: comparison between different proposals. Gen Hosp Psychiatry 2013;35:141-146.
- Porcelli P, Bellomo A, Quartesan R, Altamura M, Iuso S, Ciannameo I, Piselli M, Elisei S: Psychosocial functioning in consultation-liaison psychiatry patients: influence of psychosomatic syndromes, psychopathology and somatization. Psychother Psychosom 2009;78:352-358.
- Sattel H, Lahmann C, Gündel H, Guthrie E, Kruse J, Noll-Hussong M, Ohmann C, Ronel J, Sack M, Sauer N, Schneider G, Henningsen P: Brief psychodynamic interpersonal psychotherapy for patients with multisomatoform disorder: randomised controlled trial. Br J Psychiatry 2012;200:60-67.
- Deary V, Chalder T, Sharpe M: The cognitive behavioural model of medically unexplained symptoms: a theoretical and empirical review. Clin Psychol Rev 2007;27:781-797.
- Freidl M, Piralic Spitzl S, Prause W, Zimprich F, Lehner-Baumgartner E, Baumgartner C, Aigner M: The stigma of mental illness: anticipation and attitudes among patients with epileptic, dissociative or somatoform pain disorder. Int Rev Psychiatry 2007;19:123-129.
- Rief W, Broadbent E: Explaining medically unexplained symptoms - models and mechanisms. Clin Psychol Rev 2007;27:821-841.
- Tomba E, Bech P: Clinimetrics and clinical psychometrics: macro- and micro-analysis. Psychother Psychosom 2012;81:333-343.
- Crombez G, Beirens K, Van Damme S, Eccleston C, Fontaine J: The unbearable lightness of somatisation: a systematic review of the concept of somatisation in empirical studies of pain. Pain 2009;145:31-35.
- Sirri L, Fava GA, Sonino N: The unifying concept of illness behavior. Psychother Psychosom 2013;82:74-81.
- Mechanic D: Social psychologic factors affecting the presentation of bodily complaints. N Engl J Med 1972;286:1132-1139.
- Katsamanis M, Lehrer PM, Escobar JI, Gara MA, Kotay A, Liu R: Psychophysiologic treatment for patients with medically unexplained symptoms: a randomized controlled trial. Psychosomatics 2011;52:218-229.
- Schaefert R, Kaufmann C, Wild B, Schellberg D, Boelter R, Faber R, Szecsenyi J, Sauer N, Guthrie E, Herzog W: Specific collaborative group intervention for patients with medically unexplained symptoms in general practice: a cluster randomized controlled trial. Psychother Psychosom 2013;82:106-119.
Article / Publication Details
Copyright / Drug Dosage / DisclaimerCopyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.